Tissue Array Specification Sheet
| Product Name: | Multiple organ diseased tissues, 54 cases/54 cores, replaced by MC541 3 Slides Price: $277 , 5 Slides Price: $452 |
|---|
| Array Panel: | Multiple organ diseased tissue microarray, single core per case, 54 cases of 18 kinds of organs carcinoma (brain, esophagus, stomach, liver, colon, rectum, lung, bladder, heart, kidney and so on) |
|---|
| Cat No. |
Cases |
Layout |
Cores |
Diameter |
Thickness |
Standard IHC |
| BC00016 |
54 |
6 x 9 |
54 |
1.5 mm |
5 µm |
Anti-Cytokeratin (CK) confirmed |
Microarray Panel Display
| Legend: | Bla - Bladder,
Bra - Brain,
Bre - Breast,
Col - Colon,
Eso - Esophagus,
Hea - Heart,
Kid - Kidney,
Liv - Liver,
Lun - Lung,
Ova - Ovary,
Pan - Pancreas,
Pro - Prostate,
Rec - Rectum,
Ski - Skin,
Sto - Stomach,
Tes - Testis,
Thr - Thyroid,
Ute - Uterine cervix
 - Malignant tumor
|
Specification Sheet
| Pos |
No. |
Sex |
Age |
Organ |
Pathology diagnosis |
Grade |
Type † |
| A1 |
1 |
M |
53 |
Brain |
Astrocytoma |
II |
Malignant |
| A2 |
2 |
M |
62 |
Esophagus |
Squamous cell carcinoma |
III |
Malignant |
| A3 |
3 |
M |
66 |
Stomach |
Adenocarcinoma |
I |
Malignant |
| A4 |
4 |
M |
39 |
Liver |
Hepatocellular carcinoma with hemorrhage |
III |
Malignant |
| A5 |
5 |
M |
37 |
Colon |
Adenocarcinoma |
III |
Malignant |
| A6 |
6 |
M |
55 |
Rectum |
Adenocarcinoma |
III |
Malignant |
| A7 |
7 |
M |
66 |
Lung |
Squamous cell carcinoma |
III |
Malignant |
| A8 |
8 |
F |
76 |
Bladder |
Urothelial carcinoma |
II |
Malignant |
| A9 |
9 |
F |
37 |
Heart |
Myxoma |
- |
Malignant |
| B1 |
10 |
M |
25 |
Brain |
Astrocytoma |
I |
Malignant |
| B2 |
11 |
M |
56 |
Esophagus |
Squamous cell carcinoma |
III |
Malignant |
| B3 |
12 |
M |
65 |
Stomach |
Adenocarcinoma |
III |
Malignant |
| B4 |
13 |
F |
55 |
Liver |
Hepatocellular carcinoma |
II |
Malignant |
| B5 |
14 |
M |
58 |
Colon |
Adenocarcinoma |
II |
Malignant |
| B6 |
15 |
F |
59 |
Rectum |
Adenocarcinoma |
III |
Malignant |
| B7 |
16 |
M |
46 |
Lung |
Squamous cell carcinoma |
III |
Malignant |
| B8 |
17 |
M |
38 |
Bladder |
Urothelial carcinoma |
I |
Malignant |
| B9 |
18 |
M |
61 |
Heart |
A little myxoma |
- |
Malignant |
| C1 |
19 |
F |
15 |
Brain |
Astrocytoma |
I |
Malignant |
| C2 |
20 |
F |
72 |
Esophagus |
Squamous cell carcinoma |
II |
Malignant |
| C3 |
21 |
M |
71 |
Stomach |
Adenocarcinoma |
II |
Malignant |
| C4 |
22 |
M |
57 |
Liver |
Cholangiocellular carcinoma |
II |
Malignant |
| C5 |
23 |
F |
78 |
Colon |
Adenocarcinoma |
II |
Malignant |
| C6 |
24 |
F |
72 |
Rectum |
Adenocarcinoma |
II |
Malignant |
| C7 |
25 |
M |
59 |
Lung |
Cartilage tissue |
- |
Malignant |
| C8 |
26 |
M |
45 |
Bladder |
Urothelial carcinoma |
II |
Malignant |
| C9 |
27 |
F |
47 |
Heart |
Myxoma |
- |
Malignant |
| D1 |
28 |
M |
72 |
Kidney |
Clear cell carcinoma |
- |
Malignant |
| D2 |
29 |
M |
68 |
Thyroid |
Papillary carcinoma |
- |
Malignant |
| D3 |
30 |
F |
54 |
Pancreas |
Adenocarcinoma |
III |
Malignant |
| D4 |
31 |
F |
62 |
Uterine cervix |
Squamous cell caricnoma |
III |
Malignant |
| D5 |
32 |
F |
70 |
Skin |
Squamous cell caricnoma |
III |
Malignant |
| D6 |
33 |
F |
72 |
Breast |
Nonspecific infiltrating duct carcinoma |
III |
Malignant |
| D7 |
34 |
F |
40 |
Ovary |
Clear cell carcinoma |
- |
Malignant |
| D8 |
35 |
M |
78 |
Prostate |
Adenocarcinoma |
I |
Malignant |
| D9 |
36 |
M |
26 |
Testis |
B cell lymphoma |
- |
Malignant |
| E1 |
37 |
M |
51 |
Kidney |
Clear cell carcinoma |
- |
Malignant |
| E2 |
38 |
F |
24 |
Thyroid |
Papillary carcinoma |
- |
Malignant |
| E3 |
39 |
F |
62 |
Pancreas |
Adenocarcinoma |
III |
Malignant |
| E4 |
40 |
F |
30 |
Uterine cervix |
Squamous cell carcinoma |
III |
Malignant |
| E5 |
41 |
M |
61 |
Skin |
Steatadenoma of auriculotemporal skin |
- |
Malignant |
| E6 |
42 |
F |
45 |
Breast |
Nonspecific infiltrating duct carcinoma |
II |
Malignant |
| E7 |
43 |
F |
50 |
Ovary |
Endometrioid carcinoma |
- |
Malignant |
| E8 |
44 |
M |
73 |
Prostate |
Adenocarcinoma |
II |
Malignant |
| E9 |
45 |
M |
59 |
Testis |
Seminoma |
- |
Malignant |
| F1 |
46 |
M |
73 |
Kidney |
Clear cell carcinoma |
- |
Malignant |
| F2 |
47 |
F |
55 |
Thyroid |
Papillary carcinoma |
- |
Malignant |
| F3 |
48 |
M |
78 |
Pancreas |
Adenocarcinoma |
III |
Malignant |
| F4 |
49 |
F |
30 |
Uterine cervix |
Squamous cell carcinoma |
III |
Malignant |
| F5 |
50 |
M |
64 |
Skin |
Squamous cell carcinoma |
I |
Malignant |
| F6 |
51 |
F |
65 |
Breast |
Nonspecific infiltrating duct carcinoma |
II |
Malignant |
| F7 |
52 |
F |
40 |
Ovary |
Mucous cystadenocarcinoma |
III |
Malignant |
| F8 |
53 |
M |
81 |
Prostate |
Transitional cell carcinoma |
III |
Malignant |
| F9 |
54 |
M |
52 |
Testis |
Seminoma |
- |
Malignant |
, . † For precise diagnosis, refer to pathology description.
**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.
Staining Scoring: '-' - no staining; '+-' - borderline staining; '+' - weak staining; '++' - moderate staining; '+++' - strong staining; '%' - percentage of positive cells.
TNM grading:
T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum
N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes
M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis
